Sun Pharma: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Sun Pharmaceutical Industries Limited == | |||
[[File:Sun_Pharma_logo.svg|thumb|right|Sun Pharma Logo]] | |||
'''Sun Pharmaceutical Industries Limited''' is an Indian multinational pharmaceutical company headquartered in [[Mumbai]], [[Maharashtra]], [[India]]. It is one of the largest pharmaceutical companies in India and a leading global specialty generic pharmaceutical company. | |||
== History == | == History == | ||
Sun Pharma was founded by [[Dilip Shanghvi]] in 1983 in [[Vapi]], [[Gujarat]], with five products to treat psychiatry ailments. Over the years, the company expanded its product range and market reach through strategic acquisitions and organic growth. | |||
Sun Pharma | == Products and Services == | ||
Sun Pharma manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in [[India]] and the [[United States]]. The company offers a wide range of products in various therapeutic areas, including [[cardiology]], [[psychiatry]], [[neurology]], [[gastroenterology]], [[diabetology]], and [[dermatology]]. | |||
== | == Global Presence == | ||
Sun Pharma has a significant presence in the [[United States]], which is its largest market outside India. The company has manufacturing facilities in multiple countries, including the [[United States]], [[Canada]], [[Mexico]], [[Brazil]], [[Hungary]], [[Romania]], [[Israel]], [[Malaysia]], and [[Bangladesh]]. | |||
== Research and Development == | == Research and Development == | ||
Sun Pharma invests heavily in [[research and development]] (R&D) to develop new and innovative products. The company has R&D centers in India, Israel, and the United States, focusing on complex generics, novel drug delivery systems, and specialty pharmaceuticals. | |||
Sun Pharma | == Acquisitions == | ||
Sun Pharma has grown through several strategic acquisitions, including the acquisition of [[Ranbaxy Laboratories]] in 2014, which made it the largest pharmaceutical company in India and the fifth largest specialty generic company in the world. | |||
Sun Pharma | == Corporate Social Responsibility == | ||
Sun Pharma is involved in various [[corporate social responsibility]] (CSR) initiatives, focusing on healthcare, education, and community development. The company runs programs to provide affordable healthcare to underserved populations and supports educational initiatives in science and technology. | |||
== See also == | |||
* [[Pharmaceutical industry in India]] | * [[Pharmaceutical industry in India]] | ||
* [[ | * [[Generic drug]] | ||
* [[Dilip Shanghvi]] | |||
* [ | == Related pages == | ||
* [[Ranbaxy Laboratories]] | |||
* [[Pharmaceutical formulation]] | |||
* [[Active pharmaceutical ingredient]] | |||
[[Category:Pharmaceutical companies of India]] | [[Category:Pharmaceutical companies of India]] | ||
[[Category:Companies based in Mumbai]] | [[Category:Companies based in Mumbai]] | ||
[[Category:Companies | [[Category:Companies established in 1983]] | ||
Latest revision as of 10:48, 15 February 2025
Sun Pharmaceutical Industries Limited[edit]
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India. It is one of the largest pharmaceutical companies in India and a leading global specialty generic pharmaceutical company.
History[edit]
Sun Pharma was founded by Dilip Shanghvi in 1983 in Vapi, Gujarat, with five products to treat psychiatry ailments. Over the years, the company expanded its product range and market reach through strategic acquisitions and organic growth.
Products and Services[edit]
Sun Pharma manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers a wide range of products in various therapeutic areas, including cardiology, psychiatry, neurology, gastroenterology, diabetology, and dermatology.
Global Presence[edit]
Sun Pharma has a significant presence in the United States, which is its largest market outside India. The company has manufacturing facilities in multiple countries, including the United States, Canada, Mexico, Brazil, Hungary, Romania, Israel, Malaysia, and Bangladesh.
Research and Development[edit]
Sun Pharma invests heavily in research and development (R&D) to develop new and innovative products. The company has R&D centers in India, Israel, and the United States, focusing on complex generics, novel drug delivery systems, and specialty pharmaceuticals.
Acquisitions[edit]
Sun Pharma has grown through several strategic acquisitions, including the acquisition of Ranbaxy Laboratories in 2014, which made it the largest pharmaceutical company in India and the fifth largest specialty generic company in the world.
Corporate Social Responsibility[edit]
Sun Pharma is involved in various corporate social responsibility (CSR) initiatives, focusing on healthcare, education, and community development. The company runs programs to provide affordable healthcare to underserved populations and supports educational initiatives in science and technology.
